- Amid COVID-19, Bipartisan Letter Calls for Pharmacy DIR Reform As Part of Relief (drugtopics.com)
A bipartisan letter has urged Congress to consider including provisions permanently prohibiting pharmacy direct and indirect remuneration (DIR) clawbacks by pharmacy benefits managers (PBMs) in future coronavirus relief packages...The published letter cited increased demand and existing financial strain being amplified during the current pandemic as reasons for the bipartisan push for pharmacy DIR reform...The majority of neighborhood pharmacies are already experiencing negative cash flow issues and, for their efforts to help through this pandemic, will get a big bill months from now as PBMs come calling for DIR fees. Eliminating these fees and reining in PBMs has never been more vital if pharmacies are to continue operating now and when this emergency passes...READ MORE
- Rite Aid expands COVID-19 on-site testing: 24 locations now open across eight states (chaindrugreview.com)CVS Health expands rapid COVID-19 drive-through testing sites to Connecticut (chaindrugreview.com)Walgreens activates nine COVID-19 testing locations across five states (chaindrugreview.com)
Rite Aid continues to expand COVID-19 testing sites with eleven new locations opening Wednesday, April 22, in Delaware, Idaho, Michigan, New York, New Jersey, Ohio, Pennsylvania, and Virginia through its partnership with the U.S. Department of Health and Human Services...Now spanning eight states and 24 store locations, all of Rite Aid’s self-testing sites will be open from 9 a.m.-5 p.m. seven days a week and expect to be able to conduct approximately 200 tests each day through online appointments. In total, Rite Aid will have the capacity to conduct nearly 5,000 tests daily across all locations...READ MORE
- AbbVie, Pfizer, Novartis and more pledge millions in COVID-19 disaster relief (fiercepharma.com)
Pfizer, AbbVie, Novartis and other pharma companies are pledging millions in COVID-19 relief funds to help healthcare workers, patients and communities...Pfizer announced $40 million in both cash and grants for medical and community needs in the U.S. and around the world. In the U.S., emergency relief funds will go to government public health organizations and nonprofit community health organizations, while grants will be awarded to community health clinics for immediate and long-term needs of healthcare workers involved the COVID-19 response. Pfizer, along with Eli Lilly and Merck, previously announced a program to allow employees with medical and lab expertise to volunteer with local healthcare systems...AbbVie pledged $35 million in a COVID-19 relief package—its largest disaster donation to date—and encouraged other companies follow suit...READ MORE
- CVS to launch two new drive-through COVID-19 testing sites (reuters.com)
CVS Health Corp said that it will launch two new drive-through COVID-19 testing sites in Georgia and Rhode Island...using new, faster tests than had previously been available, with up to four more locations to follow...The company said both drive-through testing sites will use testing equipment made by Abbott Laboratories that can deliver results within minutes. It expects to be able to perform around 1,000 tests per day at each site...“We want to get some experience under our belt with these sites and understand exactly sort of what the volume looks like. And we’ll also be improving the logistics associated with each of the sites over time,” CVS Chief Medical Officer Troy Brennan said...READ MORE
- FDA Authorizes First COVID-19 Test with At-Home Sample Collection Option (drugtopics.com)
The FDA has authorized the first diagnostic test with a home collection option for coronavirus disease 2019...The FDA initially issued an emergency use authorization on March 16 for LabCorp’s RT-PCR Test, which qualitatively detects nucleic acid from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in upper and lower respiratory specimens from individuals with suspected COVID-19...LabCorp has planned to make Pixel by LabCorp COVID-19 Test home self-collection kits available with a physician’s order in most states in the coming weeks. The molecular test allows samples to be collected from a patient’s nose through a designated self-collected kit containing nasal swabs and saline. After self-collection, the sample is mailed in...to be tested...READ MORE
- State lab has plenty of capacity to test under status quo, not for widespread ‘surveillance;’ antibody tests coming soon (thenevadaindependent.com)
Though the Nevada State Public Health Laboratory has enough resources to continue testing at current levels, its capacity remains well below the level needed to conduct widespread disease surveillance to keep the spread of the novel coronavirus under control as governments begin easing restrictions on citizens, lab director Dr. Mark Pandori said...the lab is planning to bring additional equipment online in mid-May that could allow the lab to quadruple its current ability to test...“If we were to quadruple our throughput here at this lab and several other labs then we would be approaching a moment when we could start to screen well beyond just contacts of known cases and symptomatic people,” Pandori said...READ MORE
- Pharmacy Groups Praise HHS Guidance Allowing Pharmacists to Provide COVID-19 Testing (drugtopics.com)
A coalition of national and local pharmacy organizations is praising the Department of Health and Human Services’ decision to allow licensed pharmacists to order and administer COVID-19 tests during the new coronavirus disease pandemic...“The accessibility and distribution of retail and independent community-based pharmacies make pharmacists the first point of contact with a healthcare professional for many Americans,” said HHS Assistant Secretary for Health Brett P. Giroir, MD...“This will further expand testing for Americans, particularly our healthcare workers and first responders who are working around the clock to provide care, compassion and safety to others.”...READ MORE
- CDC Guidance for Community Pharmacies During COVID-19 (drugtopics.com)Guidance for Pharmacies - Guidance for Pharmacists and Pharmacy Technicians in Community Pharmacies during the COVID-19 Response (cdc.gov)Using Personal Protective Equipment (PPE) (cdc.gov)Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings (cdc.gov)
All pharmacy staff—along with everyone entering the pharmacy—should wear face masks, according to new guidance from the CDC...The CDC’s “Guidance for Pharmacists” also says that pharmacies should postpone and reschedule some routine preventive services, such as adult immunizations, since they require face-to-face interaction...This guidance applies to all pharmacy staff to minimize their risk of exposure to the virus and reduce the risk for customers during the COVID-19 pandemic...According to the guidance, pharmacies should:
Implement universal use of face coverings.
Advise staff who are sick to stay home.
Encourage all prescribers to submit prescription orders via telephone or electronically.
Limit direct contact with customers.
Reduce risk during COVID-19 testing.
Maintain social distancing
Ensure that the waiting area is cleaned regularly.
Close self-serve blood pressure units. - This Week in Managed Care: April 10, 2020 (ajmc.com)
This week, the top managed care news includes a report on how CDC lacks data to tell the full story on disparities in the COVID-19 pandemic, Medicare Advantage gets a pay bump amid COVID-19 rule changes, and the nation’s top infectious disease expert speaks with the editor-in-chief of JAMA.
- State working to fix Nevada’s coronavirus test supply shortage (reviewjournal.com)
Nevada’s northern and southern labs are out of coronavirus testing swabs, but officials expect to get more kits this week, including rapid-result test kits, Gov. Steve Sisolak said Monday...At a coronavirus briefing, Sisolak said the state has received 4,000 test swabs from the federal government and 3,000 reagent liquid kits that are used to test the samples...Sisolak said that while federal officials provided test components, “we did not get complete kits.”...State health workers continue to struggle to find enough kits to fill growing patient demands, and some clinics have shut down temporarily in Las Vegas as they wait for new supplies...READ MORE